OBJECTIVE: The advent of Electronic Medical Records (EMR) with large electronic imaging databases along with advances in deep neural networks with machine learning has provided a unique opportunity to achieve milestones in automated image analysis. Optical coherence tomography (OCT) is the most commonly obtained imaging modality in ophthalmology and represents a dense and rich dataset…
Ophthalmology Retina Template
Write in a clean editor, then format for Ophthalmology Retina in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Ophthalmology Retina format
Ophthalmology Retina is a peer-reviewed journal published by Elsevier, covering Retinal Diseases and Treatments, Retinal and Macular Surgery, Retinal Imaging and Analysis.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Ophthalmology Retina 12 (2023) 45–58.
Formats any DOI in Ophthalmology Retina style. No sign-up. |
| Publishes research in | Retinal Diseases and Treatments Retinal and Macular Surgery Retinal Imaging and Analysis Ocular Diseases and Behçet’s Syndrome Retinal and Optic Conditions |
| ISSN | 2468-6530 |
| Citation impact (2-yr) | 2.16 |
| h-index | 67 |
| i10-index | 786 |
| Total citations | 29,108 |
| Article processing charge | $3,300 |
| Top institutions publishing here | Wills Eye Hospital |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Ophthalmology Retina per year
Citation impact of Ophthalmology Retina by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Ophthalmology Retina
PURPOSE: This study assessed anti-vascular endothelial growth factor (VEGF) therapy intensity and its relationship with visual acuity (VA) change in real-world neovascular age-related macular degeneration (nAMD) patients. DESIGN: This retrospective analysis was performed on a large database of aggregated, longitudinal, de-identified electronic medical records from a geographically and demographically diverse sample of patients of United…
To evaluate the potential of machine learning to predict best-corrected visual acuity (BCVA) outcomes from structural and functional assessments during the initiation phase in patients receiving standardized ranibizumab therapy for neovascular age-related macular degeneration (AMD). Post hoc analysis of a randomized, prospective clinical trial. Data of 614 evaluable patients receiving intravitreal ranibizumab monthly or pro…